Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pascale This
Observed names:
P This,
P. This,
This, Pascale
Institution:
Institut Curie
Observed institutions:
Centre d'Échographie de la Femme et du Fœtus,
Hôpital André Mignot,
Hôpital Arnaud de Villeneuve,
Centre Hospitalier de Versailles,
Institut Curie
OpenAlex ID:
A5110141615
Prevalence and associated factors of sexual problems after early‐stage breast cancer treatment: results of a French exploratory survey
2010
·
Anne Brédart
, S. Dolbeault
, et al.
·
Psycho-Oncology
·
140
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature
2009
·
Youlia M. Kirova
, Alexia Savignoni
, et al.
·
Breast Cancer Research and Treatment
·
107
Phytoestrogens after breast cancer.
2001
·
P This
, A De La Rochefordière
, et al.
·
Endocrine Related Cancer
·
82
PDF
Controversies concerning the use of phytoestrogens in menopause management: Bioavailability and metabolism
2010
·
Patricia de Cremoux
, Pascale This
, et al.
·
Maturitas
·
58
Prophylactic salpingo‐oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation
2007
·
Fatima Laki
, Youlia M. Kirova
, et al.
·
Cancer
·
58
[Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004].
2005
·
Bruno Cutuli
, Alain Fourquet
, et al.
·
PubMed
·
44
A critical view of the effects of phytoestrogens on hot flashes and breast cancer risk
2011
·
Pascale This
, Patricia de Cremoux
, et al.
·
Maturitas
·
41
Cancer and fecundity issues mandate a multidisciplinary approach
2009
·
Dominique de Ziegler
, Isabelle Streuli
, et al.
·
Fertility and Sterility
·
38
PDF
Lack of sufficient information on the specificity and selectivity of commercial phytoestrogens preparations for therapeutic purposes
2010
·
Guy Leclercq
, Patricia de Cremoux
, et al.
·
Maturitas
·
34
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial
2011
·
Pascal Pujol
, Christine Lasset
, et al.
·
Familial Cancer
·
32
Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome
2012
·
Pascale This
, Anne de la Rochefordière
, et al.
·
Familial Cancer
·
21
Impact sur la qualité de vie et la sexualité du traitement hormonal chez les patientes atteintes d’un cancer du sein
2005
·
R. Poinsot
, A. Brédart
, et al.
·
Psycho-Oncologie
·
19
[Breast cancer and fertility: critical review, considerations and perspectives].
2008
·
Pascale This
·
PubMed
·
16
[Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].
2004
·
Pascal Pujol
, Pascale This
, et al.
·
Bulletin du Cancer
·
13
Five year letrozole versus placebo in BRCA1/2 germline mutations carriers: Final results of LIBER, a double-blind randomized phase III breast cancer prevention trial.
2020
·
Pascal Pujol
, Lise Roca
, et al.
·
Journal of Clinical Oncology
·
12
La décision médicale partagée en gynécologie
2010
·
P. This
, P. Panel
·
Gynécologie Obstétrique & Fertilité
·
12
Contraception des femmes françaises de 15 à 45ans : enquête nationale sur un échantillon représentatif de 5963 femmes
2014
·
S. Jost
, A. Le Tohic
, et al.
·
Gynécologie Obstétrique & Fertilité
·
11
Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women
2002
·
H. Rozenbaum
, O. Chevallier
, et al.
·
Climacteric
·
11
113 Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long term results and review of the literature
2010
·
Y. Kirova
, A. Savignoni
, et al.
·
European Journal of Cancer Supplements
·
10
Que penser de l’hormonoprévention du cancer du sein chez les femmes porteuses d’une mutation délétère BRCA1/BRCA2 ?
2016
·
Claire Sénéchal
, Fabien Reyal
, et al.
·
Bulletin du Cancer
·
8
Raloxifène et tissu mammaire : du concept des SERMs à la place de ce composé en pratique clinique
2003
·
P This
, B Guyot
·
Gynécologie Obstétrique & Fertilité
·
8
[Phytoestrogens in the contraindication of hormone replacement therapy. The problem of breast cancer].
2000
·
P This
, A de la Rochefordière
, et al.
·
PubMed
·
8
Après un cancer gynécologique, comment bien vivre sa sexualité?
2008
·
P. This
, M. Lachowsky
·
ONCOLOGIE
·
6
Comment prendre en compte le risque génétique de cancer du sein ? Gènes impliqués et risques tumoraux associés
2009
·
Dominique Stoppa-Lyonnet
, Bruno Buecher
, et al.
·
Bulletin de l Académie Nationale de Médecine
·
5
PDF
Special Departments
2000
·
Pascale This
, Henri Magdelenat
, et al.
·
Journal of Clinical Oncology
·
5
Show more works
View as search
Works count:
58
Citation count:
829
H-index:
13
I10-index:
19
Year
Topic
Type